Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-02-06
2007-02-06
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S328000
Reexamination Certificate
active
10513869
ABSTRACT:
The present invention relates to compounds which stimulate soluble guanylate cyclase, to the preparation thereof and to the use thereof as medicaments, in particular as medicaments for the treatment of cardiovascular disorders and/or sexual dysfunction.
REFERENCES:
patent: 19834044 (2000-02-01), None
patent: 19834045 (2000-02-01), None
patent: 19846514 (2000-04-01), None
patent: 0 463 756 (1995-04-01), None
patent: 94/28902 (1994-12-01), None
patent: 95/19978 (1995-07-01), None
patent: 98/16223 (1998-04-01), None
patent: 98/16507 (1998-04-01), None
patent: 98/23619 (1998-06-01), None
patent: 99/24433 (1999-05-01), None
patent: 00/06567 (2000-02-01), None
patent: 00/06568 (2000-02-01), None
patent: 00/06569 (2000-02-01), None
patent: 0006567 (2000-02-01), None
patent: 00/21954 (2000-04-01), None
patent: 02/42299 (2002-05-01), None
patent: 02/42300 (2002-05-01), None
patent: 02/42302 (2002-05-01), None
patent: 05/42301 (2002-05-01), None
patent: 0242299 (2002-05-01), None
patent: 0242300 (2002-05-01), None
patent: 0242301 (2002-05-01), None
patent: 0242302 (2002-05-01), None
patent: 02092596 (2002-11-01), None
patent: 03004503 (2003-01-01), None
Cavalieri, et al., “A Synthesis of Adenine. The Incorporation of Isotopes of Nitrogen and Carbon,”J. Am. Chem. Soc., 71, 533-536 (1949).
Li, et al., “Synthesis and Structure—Activity Relationships of 2-Pyridones: A Novel Series of Potent DNA Gyrase Inhibitors as Antibacterial Agents,”J. Med. Chem., 39, 3070-3088 (1996).
Beavo, et al., “Primary Sequence of Cyclic Nucleotide Phosphodiesterase Isozymes and the Design of Selective Inhibitors,” 11, 150-155 (1990).
Proposed INN: List 88,WHO Drug Information, vol. 17 No. 1 (2003).
Ko et al., YC-1, a Novel Activator of Platelet Guanylate Cyclase; Blood, 84, pp. 4226-4233 (1994).
Mülsch et al., Effect of YC-1, an NO-independent, Superoxide-Sensitive Stimulator of Soluble Guanylyl Cyclase, on Smooth Muscle Responsiveness to Nitrovasodilators; Brit. J. Pharm., 120, pp. 681-689 (1997).
Goldberg et al., Stimulation of Human Platelet Guanylate Cyclase by Fatty Acids; J. Biol. Chem., 252, pp. 1279-1285 (1977).
Pettibone et al., A Structurally Novel Stimulator of Guanylate Cyclase with Long-Lasting Hypotensive Activity in the Dog; Euro. J. of Pharmacology, 116, pp. 307-312 (1985).
Yu et al., Vasorelaxant Effect of Isoliquiritigenin, a Novel Soluble Guanylate Cyclase Activator, in Rat Aorta; Brit. J. of Pharmacology, 114, pp. 1587-1594 (1995).
Cavalieri et al., A Synthesis of Adenine: The Incorporation of Isotopes of Nitrogen and Carbon: J. Am. Chem. Soc., 71, pp. 533-536 (1949).
Borsche et al., Über die Kondensation von Säureestern mit Aliphatischen Nitrilen; Liebigs Ann. Chem., 512, pp. 97-111 (1934).
Li et al., Synthesis and Structure-Activity Relationships of 2-Pyridones: A Novel Series of Potent DNA Gyrase Inhibitors as Antibacterial Agents; J. Med. Chem., 39, pp. 3070-3088 (1996).
Beavo et al., Primary Sequence of Cyclic Nucleotide Phosphodiesterase Isozymes and the Design of Selective Inhibitors; TiPS Reviews, 11, pp. 150-155 (1990).
Bischoff et al., A Conscious-rabbit Model to Study Vardenafil Hydrochloride and Other Agents that Influence Penile Erection; Int. J. of Impotence Res., 13, pp. 230-235 (2001).
Bischoff et al., The Oral Efficacy of Vardenafil Hydrochloride for Inducing Penile Erection in a Conscious Rabbit Model; J. of Urology, 165, pp. 1316-1318 (2001).
Bischoff et al., Rabbits as Models for Impotence Research; Int. J. Impotence Res., 13, pp. 146-148 (2001).
Alonso-Alija Cristina
Bischoff Erwin
Feurer Achim
Münter Klaus
Stahl Elke
Bayer HealthCare AG
Rao Deepak
LandOfFree
Carbamate-substituted pyrazolopyridines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carbamate-substituted pyrazolopyridines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carbamate-substituted pyrazolopyridines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3880103